Home Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess
Article
Licensed
Unlicensed Requires Authentication

Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess

  • Judy L. Mintz EMAIL logo , Morghan B. Jameson , Leah Akinseye and Evan A. Los
Published/Copyright: April 12, 2021

Abstract

Objectives

Report a novel case of new-onset type 1 diabetes in a pediatric patient presenting with DKA and concurrent Streptococcus intermedius brain abscess.

Case presentation

The following case report is that of a previously healthy 12 year-old girl presenting with new-onset type 1 diabetes with mild diabetic ketoacidosis and subsequently found to have a brain abscess. Over the course of her hospital stay, she developed seizures and was found to have a 1.3 × 1.0 × 1.2 cm right frontal parasagittal mass culture-positive for S. intermedius. Neurologic symptoms were unmasked once insulin treatment was initiated and ketosis improved, supporting the relationship between therapeutic ketosis and the management of medication-refractory epilepsy.

Conclusions

This case both supports the relationship between therapeutic ketosis and the management of medication-refractory epilepsy and highlights the need to carefully consider comorbid conditions in patients with DKA and new onset neurological symptoms.


Corresponding author: Judy L. Mintz, East Tennessee State University James H Quillen College of Medicine, Johnson City, Tennessee, USA, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed Consent: Informed consent was obtained from individuals included in this case report.

  5. Ethical approval: Research involving human subjects complied with all relevant national and institutional regulations and has been approved by the authors’ Institutional Review Board or equivalent committee.

References

1. Haller, M, Atkinson, M, Schatz, D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin N Am 2005;52:1553–78.10.1016/j.pcl.2005.07.006Search in Google Scholar PubMed

2. Lee, E, Lee, M, Hung, Y, Wang, L. Orbital rhinocerebral mucormycosis associated with diabetic ketoacidosis: report of survival of a 10-year-old boy. J Formos Med Assoc 1998;97:720–3.Search in Google Scholar

3. Mishra, A, Fournier, P. The role of Streptococcus intermedius in brain abscess. Eur J Clin Microbiol Infect Dis 2013;32:477–83.10.1007/s10096-012-1782-8Search in Google Scholar PubMed

4. Issa, E, Salloum, T, Tokajian, S. From normal flora to brain abscesses: a Review of Streptococcus intermedius. Front Microbiol 2020;11:826.10.3389/fmicb.2020.00826Search in Google Scholar PubMed PubMed Central

5. Nguyen, A, Allison, R, Maynard, K, Patterson, J. Kocuria rhizophila intracerebral abscess in diabetic ketoacidosis. J Neuroinfectious Dis 2018;9:275.10.4172/2314-7326.1000275Search in Google Scholar

6. Strickland, B, Pham, M, Bakhsheshian, J, Carmichael, J, Weiss, M, Zada, G. Endoscopic endonasal transsphenoidal drainage of a spontaneous Candida glabrata pituitary abscess. World Neurosurg 2018;109:467–70.10.1016/j.wneu.2017.10.060Search in Google Scholar PubMed

7. Esposito, S, Bosis, S, Dusi, E, Cinnante, C, Principi, N. Brain abscess due to Streptococcus intermedius in a 3-year-old child. Pediatr Int 2011;53:1104–5.10.1111/j.1442-200X.2011.03479.xSearch in Google Scholar PubMed

8. Petti, C, Simmon, K, Bender, J, Blaschke, A, Webster, K, Conneely, M. Culture-Negative intracerebral abscesses in children and adolescents from Streptococcus anginosus group infection: a case series. Clin Infect Dis 2008;46:1578–80.10.1086/587655Search in Google Scholar PubMed

9. Martin, K, Jackson, CF, Levy, RG, Cooper, PN. Ketogenic diet and other treatments for epilepsy. Cochrane Database Syst Rev 2016;2:CD001903. https://doi.org/10.1002/14651858.CD001903.pub3.Search in Google Scholar

10. Kominsky, DJ, Campbell, EL, Colgan, SP. Metabolic shifts in immunity and inflammation. J Immunol 2010;184:4062–8. https://doi.org/10.4049/jimmunol.0903002.Search in Google Scholar

Received: 2020-12-14
Accepted: 2021-01-18
Published Online: 2021-04-12
Published in Print: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Provocative growth hormone testing in children: how did we get here and where do we go now?
  4. Original Articles
  5. Mental and somatic health in university students with type 1 diabetes: new results from DiaSHoT18, a cross sectional national health and well-being survey
  6. Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children
  7. What is the relationship between obesity and new circadian rhythm parameters in Turkish children and adolescents? A case-control study
  8. Body fat distribution in trunk and legs are associated with cardiometabolic risk clustering among Chinese adolescents aged 10–18 years old
  9. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case–control study
  10. Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years
  11. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study
  12. Levels of physical activity and barriers to sport participation in young people with gender dysphoria
  13. Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity
  14. Validation of a continuous measure of cardiometabolic risk among adolescents
  15. Clinical characteristics and molecular genetic analysis of a cohort with idiopathic congenital hypogonadism
  16. The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A
  17. Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets
  18. Case Reports
  19. Asymptomatic pituitary apoplexy induced by corticotropin-releasing hormone in a 14 year-old girl with Cushing’s disease
  20. Two patients from Turkey with a novel variant in the GM2A gene and review of the literature
  21. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate
  22. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0711/html
Scroll to top button